Isolation and Identification of Canine Parvovirus Type 2 in Dogs from Algeria

Using intraperitoneal (I. P. ) inoculation of a commercial canine parvovirus vaccine we were able to prepare an anti-parvovirus serum. By performing indirect immuno- fluorescence (IFd) we characterized three virus isolates from the fecal samples of 12 dogs presenting with clinical signs of canine parvovirus (CPV) disease. Serum neutralization tests on CRFK cells with the reference serum confirmed the identity of these isolates as CPV thereby representing the first isolation of this canine virus in Algeria.